J9308 HCPCS Level II Code: Injection, ramucirumab, 5 mg
HCPCS Level II code, maintained by CMS. Not a CPT code: CPT (HCPCS Level I) is a separate AMA code set that MedCoder does not publish. About HCPCS Level II
Compare with another codeCheck this code on a claim
Coding at a Glance
- Drug products
- 2 NDC products
- CMS cross-references
- 1 related code
Medicare Coverage & Payment
- CMS short descriptor: Injection, ramucirumab
Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.
Coding context
Guidelines, coding notes, decision aids, relationships (with MS-DRG and CCSR classification), hierarchy, HCC, coverage and the context map: what a coder reaches for after the core. Each section names whether it is official source data, a MedCoder-derived relationship or MedCoder editorial.
Related Codes
CMS cross-reference from deleted or non-Medicare codes
The CMS HCPCS Level II code set cross-references these codes (deleted or not valid for Medicare) to this code.
Drug products (NDC)
CMS ASP NDC-HCPCS Crosswalk · 2026 Q4
Medicare Part B payment limit (ASP + 6%): $76.40
00002-7669-01 — Cyramza — Eli Lilly and Company (size 10 × qty 1 (5 MG per billing unit))
00002-7678-01 — Cyramza — Eli Lilly and Company (size 50 × qty 1 (5 MG per billing unit))
From the CMS ASP NDC-HCPCS Crosswalk and Part B Payment Limit File. Payment limits apply per HCPCS billing code, not per package.
Contextual Map
Every relationship of J9308 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.
Nearest codes (40)
- J9300 — Injection, gemtuzumab ozogamicin, 5 mg[Sibling]— CMS HCPCS Level II code set
- J9301 — Injection, obinutuzumab, 10 mg[Sibling]— CMS HCPCS Level II code set
- J9302 — Injection, ofatumumab, 10 mg[Sibling]— CMS HCPCS Level II code set
- J9303 — Injection, panitumumab, 10 mg[Sibling]— CMS HCPCS Level II code set
- J9304 — Injection, pemetrexed (pemfexy), 10 mg[Sibling]— CMS HCPCS Level II code set
- J9305 — Injection, pemetrexed, not otherwise specified, 10 mg[Sibling]— CMS HCPCS Level II code set
- J9306 — Injection, pertuzumab, 1 mg[Sibling]— CMS HCPCS Level II code set
- J9307 — Injection, pralatrexate, 1 mg[Sibling]— CMS HCPCS Level II code set
- and 32 more
CMS cross-reference
- C9025 — Injection, ramucirumab, 5 mg[Cross-referenced from]— CMS HCPCS Level II code set (cross-reference field) · OCT2026
Change history
- January 1, 2016 — Added to the code set [Change history]— CMS release files (code change ledger)
Reference
Index terms and tables, published questions and FAQ, every source behind this page with its release and checksum, the date-of-service check and the complete change history.
Sources for this page
Codes, titles, notes, index terms and mappings on this page are transcribed from the datasets below. Relationships MedCoder computed and text MedCoder wrote are labelled where they appear.
- Code, descriptors, coverage and pricing attributes Official source data
- CMS HCPCS Alpha-Numeric (ANWEB) release — October 2026 quarterly update Release, file and checksum · Publisher’s page
- Drug products Official source data
- CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release); FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24 Release, file and checksum · Publisher’s page
- Change history and date-of-service validity Official source data
- CMS HCPCS quarterly update files, ingested into the change ledger Release, file and checksum · Publisher’s page
- Comparisons, relationships and the contextual map MedCoder-derived relationship
- Computed by MedCoder from the tabular notes and tables above; every derived relationship is marked as derived where it appears
- Summary and FAQ answers MedCoder editorial explanation
- Written by MedCoder to explain the sources above: drafted with AI assistance, checked by a person against the release files, and labelled as MedCoder text where it appears. Not official text.
Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 20, 2026 · All releases and sources
Labels on this page: Official source data · MedCoder-derived relationship · MedCoder editorial explanation. How to read the labels · All data sources and release dates · CMS coding rules
Cite this page
Reference this page in a research guide, syllabus or article. The release is included because code content changes each year.
MedCoder.ai. "J9308 — Injection, ramucirumab, 5 mg." HCPCS Level II October 2026. https://medcoder.ai/hcpcs/code/j9308-injection-ramucirumab-5-mg
Change history
- January 1, 2016Added to the code setInjection, ramucirumab, 5 mgHCPCS 2016 changes
Nearest Codes in This Family
Official HCPCS Level II classifications closest to J9308 in its code family, with their registry titles.
- J9303 — Injection, panitumumab, 10 mg
- J9304 — Injection, pemetrexed (pemfexy), 10 mg
- J9305 — Injection, pemetrexed, not otherwise specified, 10 mg
- J9306 — Injection, pertuzumab, 1 mg
- J9307 — Injection, pralatrexate, 1 mg
- J9309 — Injection, polatuzumab vedotin-piiq, 1 mg
- J9310 — Injection, rituximab, 100 mg
- J9311 — Injection, rituximab 10 mg and hyaluronidase
- J9312 — Injection, rituximab, 10 mg
- J9313 — Injection, moxetumomab pasudotox-tdfk, 0.01 mg